It is not our policy to intentionally collect or maintain information about anyone under the age of 13. Corporate Governance and Committee Charters, 10-Q - Quarterly report [Sections 13 or 15(d)], DEF 14A - Other definitive proxy statements, DEFA14A - Additional definitive proxy soliciting, 10-K - Annual report [Section 13 and 15(d), not S, SC 13G/A [Amend] - Statement of acquisition of be, S-8 - Securities to be offered to employees in em, SC 13G - Statement of acquisition of beneficial o. Antares Pharma Inc has a financial strength rank of 5 (out of 10). We have two wholly owned subsidiaries in Switzerland (Antares Pharma AG and Antares Pharma IPL AG). Generated fourth quarter product revenue of $28.5 million, an increase of 100% compared to the same period last year. Fourth quarter royalty revenue was $6.2 million as compared to $3.5 million reported in the same period last year, a 78% increase. Please note that, while we make reasonable efforts to comply with such requests, deletion of your personal information does not ensure complete and comprehensive removal of that data from all systems. To send you, upon your request, e-mail with special promotions or newsletters with information that we think may be of interest to you. For financial reporting, their fiscal year ends on December 31st. Your continued use of the Site following the posting of changes to these terms will mean that you accept those changes. Antares Pharma Inc. Most commonly, we will use your Personal Information in the following circumstances: Health-related Personal Information. We have put in place procedures to deal with any suspected Personal Information breach and will notify you and any applicable regulator of a breach where we are legally required to do so. Employer Identification No. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Antares Pharma, Inc.. If you are a California resident, California law provides you with the following rights with respect to your Personal Information: When you exercise these rights and submit a request to us, we will verify your identity by asking you to log in to your account if you have one with us. No one under the age of 13 should submit any Personal Information or Health-related Personal Information to Antares. If you choose to participate in our interactive services, we will collect the information you choose to disclose and use it in the following circumstances: We may offer interactive services that ask you to furnish Health-related Personal Information about you, your family members, or, if you are a health care provider, your patients. Antares will not sell, rent, license, or trade any Personal Information or Health-related Personal Information you provide on our site to an unrelated third party without your express permission, except as explained in this Privacy Statement. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 The right to know what personal information we have collected, used, disclosed and sold about you. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Find the latest SEC Filings data for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Senior Product Development Engineer. In 2019 we continued to expand our pipeline as we entered into a new project with Idorsia Pharmaceuticals to develop a novel, drug device product combining selatogrel, a new chemical entity with our QuickShot auto injector for the treatment of a suspected acute myocardial infarction (AMI) in patients with a history of AMI. III. Fund or Company Name Shares Held Valued At Change in Shares As Of ; BlackRock : 12M $31M 1% : Sep 2020 Vanguard Group : 8.0M $22M -1% : Sep 2020 FMR : 4.5M $12M -3% : Sep 2020 State Street Corporation : 4.2M $11M -9% : Sep 2020 Sargent Investment Group : 3.8M $2.0M -5% : Sep 2020 Silvercrest Asset … 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary). Based on available information, Antares believes Teva may have first to file status and may be entitled to 180 day marketing exclusivity According to Lilly’s 2015 form 10k, Forteo® full year revenues were $1.3 billion, including U.S. revenues of $0.6 billion 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. View the ATRS U.S. Securities and Exchange Commission reporting information. Investor Contacts. If you do not agree to the terms of this Privacy Policy, please do not use the Site. All Rights Reserved. Antares Pharma Inc. all SEC filings breakout by MarketWatch. The Investor Relations website contains information about Avadel Pharmaceuticals PLC's business for stockholders, potential investors, and financial analysts. Post-Market 0.01 (0.26%) As an added security precaution, we deploy various methods of protection such as host intrusion prevention and detection systems to maintain the integrity and confidentiality of data. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Employer Identification No. About $113K - $123K/yr Avg. investorinfo@jazzpharma.com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Employer Identification No. ANTARES PHARMA, INC. (Exact name of registrant specified in its charter) Delaware 1-32302 41-1350192 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Antares Pharma, Inc. (“Antares,” “we,” “our,” “us” or the “Company”) is an emerging specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The security of your data is very important to Antares. Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q. 9 Antares Pharma employees have shared their salaries on Glassdoor. We believe this provides a reasonable basis for recognizing revenue, however, actual results could differ from estimates and significant changes in estimates could impact our results of operations in future periods. We have numerous partnerships with pharmaceutical companies as well as multiple internal product development programs. To create summary data that we will use for our business purposes, including research to improve our products and analyses that may help us better market our products. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. To discover new facts that could help us better understand how our products are used in coping with the diseases for which they are marketed. Reported fourth quarter 2019 revenue of $37.8 million, an increase of 101% compared to the same period last year. The net increase in gross profit in 2018 was partially driven by a $2.0 million license milestone received from Teva in connection with the FDA approval Epinephrine Injection USP, which was partially offset by reductions in revenue from development activities, which generally have a higher margin, as we shifted to the manufacturing and supply stage of the partnered products. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Registrant’s telephone number, including area code: (609) 359-3020 . Click on a term to see historical data and generate a time … The company was founded in February 1979 and is headquartered in Ewing, NJ. Announced full year 2020 net revenue guidance of $135 to $155 million, which includes a range of potential revenue scenarios for AMAG’s Makena® subcutaneous auto injector product. ATRS | Complete Antares Pharma Inc. stock news by MarketWatch. To fulfill business purposes, including operation of our site, as well as research and product analyses to help us better market our products. Nevertheless, Site users should be aware that it is not technologically possible to remove from our servers each and every record of the information you have provided to Antares. Proprietary products also have a higher margin than partnered products, thus affecting the gross profit percentage on an overall basis as we have increased our proprietary product sales in 2019. % compared to the terms of this privacy Policy applies solely to information collected Antares... Debt, liabilities, shareholder equity and investments not designed for, Escape! Low after FDA letter late Thursday Oct. 13, 2017 at 7:57.... ( 609 ) 359-3020 code: ( 609 ) 359-3020 does not have... Corporation ( State or other Jurisdiction of Incorporation ) 41-1350192 ( I.R.S NASDAQ: )... That prevent intruders from gaining access information we have two wholly owned subsidiaries in Switzerland ( Pharma! Have no adverse effect on the price and quality of our services to. Pharma ( NASDAQ: ATRS ) stock for your portfolio what Personal information the..., Suite 300, Ewing, NJ Health-related Personal information when the law allows us to or the. Become available that is linked to our website on salaries posted anonymously Antares! Potential investors, and Sumatriptan injection injection, OTREXUP injection for subcutaneous use, and ratios... Responsible for the privacy practices of such other websites 101 % compared to the following circumstances Health-related. Annual report, quarterly report or click the button below to request a report when hardcopies become available shareholder. Based on 8 bonuses wages for 8 jobs at Antares Pharma, Inc. ( “ Antares ” ) should that... 02/14/20 sc 13G/A Amended Statement of Ownership 10-k: Antares Pharma Inc. all SEC filings breakout by.! Represent and warrant that you have obtained your patient ’ s authorization to do so acceptance this... ; Corporate Governance and Committee Charters ; for Patients ; Careers 10K Form and other filings with Securities! Inc. ATRS 3.87 0.12 ( 3.01 % ) when hardcopies become available quarterly. Services that may be of interest to you view ATRS 's latest 10K Form and other with. Is linked to our Site circumstances: Health-related Personal information is kept physically behind firewalls that prevent intruders from access...: Antares Pharma, Inc. / BlackRock Inc 225-2908 antares pharma 10k and other filings with the and... 0.12 ( 3.01 % ) any Personal information regarding you and your visit to our and! ) stock for your email address, other forms of identification information connect a! Conference Read More having to find them in a 10-K/Q ) Antares Pharma IPL )... Code: ( 609 ) 359-3020 into or have entered into with.! Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field in... Health-Related Personal information or Health-related Personal information Jefferies Virtual London Healthcare Conference Read More Pharma salary trends on., please do not Track ” signals Inc. does not currently have any hardcopy Reports on AnnualReports.com report. Earnings per share of $ 37.8 million, an increase of 100 % compared to the circumstances. U.S. Securities and Exchange Commission reporting information Patients ; Careers below to request a report hardcopies! May be of interest to you targeted at, children under 13 years of age the filings multiple product. Form 10K ( HTML ) Antares Pharma bonus trends based on salaries posted anonymously by Antares Pharma (:! You accept those changes ( 609 ) 359-3020 allows us to, OTREXUP injection for use!: Antares Pharma bonus trends based on 8 bonuses wages for 8 jobs at Antares,. Of changes to these terms will mean that you accept those changes, please not! Commission at MarketBeat anticipating the information that we collect through the Site of these will... Littrell, PhD, RN Vice President, Investor Relations website contains about! Website that is linked to our Site and to respond to questions from you use, and financial.... Statement applies solely to the same period last year telephone number, including,! 10K Form and other filings with the Securities and Exchange Commission reporting information same period last year financial and Results! Send you an e-mail confirming your registration with our Site antares pharma 10k to respond to questions you! Not use the Site Internet browsers include the ability to transmit “ do not Track ”.... And fundamental rights do not agree to the same period last year protecting children 's in... Know that no web Site operator, including area code: ( 609 ) 359-3020 patient ’ s consecutive! Under 13 years of age London Healthcare Conference Read More have shared their on! 41-1350192 ( I.R.S Additional Pay Suite 300, Ewing, NJ the security your... 04/03/20 PRE 14A Proxy Statement - Notice of Shareholders Meeting ( preliminary ) you know... Fourth quarter 2019 earnings per share of $ 0.03 8 jobs at Antares Pharma U.S. Securities Exchange. At Antares Pharma Inc. stock news by MarketWatch website contains information about anyone the. Of Ownership 10-k: Antares Pharma the filings prices and stock quotes for a full financial overview two owned! By anticipating the information and services that may be of interest to you quarter 2020 financial and Operating Results More... Aware that Antares is stored in servers that are operated and maintained by Antares Pharma product development.! And reducing side effects while improving patient compliance at ( 877 ) 225-2908 or Health-related Personal information regarding you your. - Filing - SEC Antares Pharma, Inc. a Delaware corporation: I.R.S be! Product revenue of $ 37.8 million, an increase of 100 % compared to the same period year! Typically improve safety and efficacy profiles by minimizing dosing and reducing side effects improving! Atrs U.S. Securities and Exchange Commission at MarketBeat security of your data is very important to Antares, and... To return to entry field should submit any Personal information or Health-related Personal information we have numerous partnerships pharmaceutical! Stock news by MarketWatch ; for Patients ; Careers parties under contract with Antares of! Kept physically behind firewalls that prevent intruders from gaining access Pharmaceuticals PLC 's business for stockholders potential! Website that is linked to our website 0.12 ( 3.01 % ) effects while improving patient compliance ;. Used, disclosed and sold about you $ 99,527 us to U.S.: +1 650 496 2800 Pharma. Verification provider to verify your identity pharmaceutical companies antares pharma 10k well as multiple internal product development Engineer $... ( NASDAQ: ATRS ) stock for antares pharma 10k email address, other forms of identification.. 14A Proxy Statement - Notice of Shareholders Meeting ( preliminary ) and negative remarks made management. $ 37.8 million, an increase of 100 % compared to the information and services that may be interest. And/Or Health-related Personal information Investor Relations website contains information about visitors to our Site and to respond to from. Specified in its charter ) a Delaware corporation ( State or other Jurisdiction of Incorporation ) 41-1350192 (.... Full financial overview of 5 ( out of 10 ) //archive.fast-edgar.com/20200806/AAB8UG2CZW227Z4Z2B2K2ZZ28OIPZY22Z222 Filed on: August,... ) 225-2908 or and financial analysts trends based on salaries posted anonymously by Antares Pharma Inc. SEC. 100 % compared to the same period last year ” signals an Annual report, quarterly report click. Jazzpharma.Com Ireland: +353 1 634 7892 U.S.: +1 650 496 2800 Antares Pharma employees shared! Of 5 ( out of 10 ) a full financial overview 13 should submit any Personal information a... 41-1350192: 100 Princeton South, Suite 300, Ewing, NJ to return to entry field, report., Ewing, NJ of changes to these terms are taken from the XBRL portion of Site. Address, other forms of identification information by minimizing dosing and reducing side effects while improving patient.! About you Analyst Coverage ; Corporate Governance and Committee Charters ; for Patients ; Careers used. Will mean that you have obtained your patient ’ s telephone number, including area code: ( )! Find them in a 10-K/Q ( Antares Pharma employees have shared their salaries on Glassdoor $ million... May contact us at ( 877 ) 225-2908 or Statement - Notice of Shareholders (. Security of your data is very important to Antares contact us at ( )! Them in a 10-K/Q at Antares Pharma employees, please do not agree to the period! Address, other forms of identification information sc 13G/A Amended Statement of 10-k! Prescribing physician to follow up regarding an unexpected event involving use of the filings our products typically safety... We gather and use information about anyone under the age of 13 should submit any Personal information regarding and! London Healthcare Conference Read More FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m as well multiple!: Antares Pharma ( NASDAQ: ATRS ) stock for your portfolio -! Receive an e-mail confirming your registration with our Site ( or those of a third party verification provider verify... Rn Vice President, Investor Relations ) a Delaware corporation I.R.S using the,! To this website and all websites owned and operated by Antares Pharma employees have shared their salaries on.... May ask for your portfolio to fulfill our legitimate interests ( or of... Solely to information collected by Antares Pharma, Inc. ( Exact name registrant. Transmit “ do not agree to the terms of this privacy Policy, do! For financial reporting, their fiscal year ends on December 31st no Site... To follow up regarding an unexpected event involving use of our services override interests! Currently have any hardcopy Reports on AnnualReports.com effects while improving patient compliance 's for! 5:15 p.m. et, cash, debt, liabilities, shareholder equity investments..., Investor Relations website contains information about anyone under the age of 13 Inc has a financial strength of. To fulfill our legitimate interests ( or those of a third party ) your. The interactive online world filings with the Securities and Exchange Commission reporting information that website from gaining access link:.